Location History:
- Oxford, GB (2013 - 2016)
- Newcastle upon Tyne, GB (2019)
Company Filing History:
3 out of 263 
1 out of 832,966 Years Active: 2013-2019
Title: Martin Noble: Innovator in Therapeutic Agents
Introduction
Martin Noble is a distinguished inventor based in Newcastle upon Tyne, GB. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of cancer. With a total of 4 patents to his name, Noble's work has the potential to impact medical science profoundly.
Latest Patents
Noble's latest patents include innovative compounds aimed at treating cancer. One of his notable inventions is a compound of formula (I) or formula (II), along with pharmaceutically acceptable salts, which are designed to inhibit the interaction of the MDM2 protein with p53. This invention holds promise for cancer therapy. Another significant patent involves pyrrolcarboxamide derivatives that inhibit ERK5. These compounds are useful for the prophylaxis or treatment of diseases mediated by ERK5, particularly various cancers.
Career Highlights
Throughout his career, Martin Noble has worked with reputable organizations, including Cancer Research Technology Limited. His expertise in developing therapeutic agents has positioned him as a key figure in the fight against cancer.
Collaborations
Noble has collaborated with notable individuals in his field, including Bernard Thomas Golding and Roger John Griffin. These partnerships have likely contributed to the advancement of his innovative work.
Conclusion
Martin Noble's contributions to therapeutic agents and cancer treatment exemplify the impact of innovation in medicine. His patents reflect a commitment to improving health outcomes through scientific discovery.